Clinical Trials at Providence Medical Foundation
As of August 2026, 16 paid clinical trials are recruiting at Providence Medical Foundation, located at 500 DOYLE PARK DR, SUITE 303, SANTA ROSA, CA 95405-4558, phone (707) 303-8300 in Santa Rosa, California. Active studies at this site cover conditions such as Anatomic Stage II Breast Cancer AJCC v8, Endometrial Cancer and Lung Non-Small Cell Carcinoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
16 clinical trials at Providence Medical Foundation
·Clear filters·A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Common conditions studied in Santa Rosa
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Endometrial Cancer (4 active studies)
- Lung Non-Small Cell Carcinoma (4 active studies)
- Non-Small Cell Lung Cancer (4 active studies)
- Stage IV Lung Cancer AJCC v8 (4 active studies)
- Acute Myeloid Leukemia (3 active studies)
Leading research sponsors in Santa Rosa
- SWOG Cancer Research Network
- NRG Oncology
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Santa Rosa?
There are approximately 108 recruiting clinical trials in Santa Rosa, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Santa Rosa pay participants?
Most recruiting trials in Santa Rosa compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Santa Rosa?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Santa Rosa?
The most common conditions under active study in Santa Rosa include Anatomic Stage II Breast Cancer AJCC v8 (4), Endometrial Cancer (4), Lung Non-Small Cell Carcinoma (4), Non-Small Cell Lung Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Santa Rosa?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Santa Rosa on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Santa Rosa?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Santa Rosa?
Recruiting research sites in Santa Rosa include Kaiser Permanente-Santa Rosa, Providence Medical Foundation - Santa Rosa, Providence Santa Rosa Memorial Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Santa Rosa right now?
The largest active categories in Santa Rosa are Cancer & tumors (79), Cardiovascular (6), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Providence Medical Foundation?
Providence Medical Foundation is located at 500 DOYLE PARK DR, SUITE 303, SANTA ROSA, CA 95405-4558. Use the Google Maps link in the intro above to get directions.
How do I contact Providence Medical Foundation?
You can reach Providence Medical Foundation by phone at (707) 303-8300. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.